Laurie Carr

LOW-DOSE AMINOGLUTETHIMIDE IN TREATMENT OF ADVANCED BREAST CANCER

R. Stuart‐Harris, Thomas Bozek, J C Gazet et al. · The Lancet · 1984 · 62 citations

Medicine, Pharmacology, Breast Cancer +5

Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC)

Bernardo Goulart, Laurie Carr, R. G. Martins et al. · Journal of Clinical Oncology · 2008 · 32 citations

Iodine Refractory, Phase Ii Study, Disease Refractory +16

Phase II trial of continuous dosing of sunitinib in advanced, FDG-PET avid, medullary thyroid carcinoma (MTC) and well-differentiated thyroid cancer (WDTC)

Laurie Carr, Bernardo Goulart, Renato Martins et al. · Journal of Clinical Oncology · 2009 · 21 citations

Metronomic Chemotherapy, Neuro-oncology, Oncology +19

Clinical Utility of Routine Proteinuria Evaluation in Treatment Decisions of Patients Receiving Bevacizumab for Metastatic Solid Tumors

Jason Yen, Deborah Frieze, Renato Martins et al. · Annals of Pharmacotherapy · 2010 · 20 citations

Estimates of stage-specific preclinical sojourn time across 21 cancer types.

Michael S. Broder, Sikander Ailawadhi, Himisha Beltran et al. · Journal of Clinical Oncology · 2021 · 12 citations

Dwell Times, Cancer Management, Prognosis +18